Key Highlights

  • Fabrinet (NYSE:FN) reports after the close on Monday, November 2, 2026 with an options-implied move of 21.4 percent as of October 30, the largest of the four and among the biggest swings priced for the week.
  • ON Semiconductor (NASDAQ:ON) reports after the close on November 2, 2026 with an implied move of 10.5 percent, a chip read-through that arrives days after the Philadelphia Semiconductor index fell about 7.2 percent in one session.
  • IDEXX Laboratories (NASDAQ:IDXX) reports before the open on November 2, 2026 with an implied move of 9.3 percent, putting the spotlight on veterinary diagnostics Demand at a time when most Earnings attention is on technology.
  • Vertex Pharmaceuticals (NASDAQ:VRTX) reports after the close on November 2, 2026 with the smallest implied move of the four at 5.9 percent, a large biotech print whose consensus figures were not confirmed for this article.

Fabrinet (NYSE:FN): The 21.4 Percent Question

Fabrinet (NYSE:FN) reports after the close on Monday, November 2, 2026, and Options priced as of October 30 imply a move of 21.4 percent, more than double the figure for the next company in this group. An implied move is the size of the swing that option prices suggest around an event, up or down, derived from what traders pay for options, and it does not predict direction. The company is an optical and AI Supply chain manufacturer, so investors read its results as a gauge of demand for the components that connect AI data centers. That makes it exposed to the same fear that hit chip shares on October 30, when the Philadelphia Semiconductor Index fell about 7.2 percent and Advanced Micro Devices (NASDAQ:AMD) fell roughly 10 percent. Consensus figures were not confirmed for this article, so readers should check published estimates for revenue, earnings and guidance. Customer concentration is a typical risk for manufacturers serving a few large buyers, and any change in orders can move results quickly. A beat can still disappoint if the outlook is cautious, because the implied move shows expectations are already stretched.

ON Semiconductor (NASDAQ:ON): A Chip Read-Through After the Crash

ON Semiconductor (NASDAQ:ON) reports after the close on November 2, 2026 with an implied move of 10.5 percent as of October 30. The report matters beyond the company because it follows a bruising session for semiconductors, when the Philadelphia Semiconductor Index lost about 7.2 percent and Intel (NASDAQ:INTC) crashed 28.58 percent on weak guidance and a warning that the PC slowdown would run through at least the first half of 2027. Investors will look for evidence on whether demand across end markets is holding or weakening, and for commentary on inventory, because chipmakers with too much stock must cut production and margins can suffer. Consensus figures were not confirmed for this article, so check published estimates before the release. The size of the implied move is large for a semiconductor company and reflects sentiment that has turned sharply. Risks include a weak outlook, price competition and customers delaying orders. The result will be read for the company and also for what it says about the wider chip cycle.

IDEXX Laboratories (NASDAQ:IDXX): Veterinary Diagnostics in Focus

IDEXX Laboratories (NASDAQ:IDXX) reports before the open on November 2, 2026 with an implied move of 9.3 percent as of October 30. The company sells diagnostic instruments and tests used by veterinary clinics, so results depend on the number of pet visits, how often clinics run tests and the price they pay for consumables. Recurring consumables tend to make this kind of model more predictable than one-off equipment sales, but a stock priced for steady growth can fall hard when the outlook softens, which helps explain why a move of nearly 10 percent is priced in. Consensus figures were not confirmed for this article, so readers should check estimates for revenue, Earnings Per Share and full-year guidance. The report comes before the market opens, so the reaction will be visible in early trading and may already be known to readers who see this later in the day. Risks include lower clinic visits, pricing pressure and currency swings. In a week dominated by AI names, a result from outside technology offers a different read on consumer spending on pets.

Vertex Pharmaceuticals (NASDAQ:VRTX): The Smallest Implied Move at 5.9 Percent

Vertex Pharmaceuticals (NASDAQ:VRTX) reports after the close on November 2, 2026, with options implying a move of 5.9 percent as of October 30, the smallest of the four. That is moderate for a biotech, and it suggests that traders see the report as a lower-risk event than the other three. The company is a large biotech, and results are driven by sales of approved medicines and by progress in the pipeline, where a trial result can matter as much as quarterly revenue. Consensus figures were not confirmed for this article, so readers should check published estimates for revenue, earnings per share and guidance. A smaller implied move does not mean a smaller risk: a surprise on guidance or a pipeline update can still move the stock more than options suggest. The broader market context also matters, because healthcare names such as Regeneron (NASDAQ:REGN) rose on October 30 while technology fell, and investors are looking for shelter. Risks include pricing pressure, competition and clinical or regulatory setbacks. The after-the-close timing means the reaction comes on November 3.

Where Things Stand

The biggest swing risk sits with Fabrinet (NYSE:FN), whose 21.4 percent implied move is the largest of the four and reflects exposure to the AI supply chain after the chip crash. ON Semiconductor (NASDAQ:ON) follows at 10.5 percent as a read-through on semiconductors. IDEXX Laboratories (NASDAQ:IDXX) is priced for 9.3 percent. Vertex Pharmaceuticals (NASDAQ:VRTX) carries the smallest figure at 5.9 percent. The ranking rests on options pricing as of October 30, not on results, and consensus figures were not confirmed. Implied moves describe size, not direction. The next catalysts are the four releases on November 2, 2026 and the jobs report on November 6. This is not Investment advice.